Table 2.
CMR index | Baseline (N ≤ 331) |
Follow-up (N ≤ 238. 72%) |
||
---|---|---|---|---|
N | Mean (or N) | N | Mean (or N) | |
LVESVI (ml/m2) | 331 | 39.4 ± 16.5 | 238 | 36.8 ± 13.1 |
LV mass index (g/m2) | 319 | 60.0 ± 14.5 | 226 | 57.5 ± 13.0 |
LV ejection fraction, % | 331 | 53.9 ± 9.4 | 238 | 56.6 ± 7.9 |
RV ejection fraction, % | 331 | 53.3 ± 7.1 | 239 | 52.6 ± 7.7 |
Late gadolinium enhancement, g | 327 | 17.4 ± 17.2 | 244 | 14.0 ± 13.9 |
Average extracellular volume fraction | 255 | 0.34 ± 0.05 | 192 | 0.35 ± 0.05 |
ΔLVESVI | – | 238 | −2 ± 19% | |
ΔLV mass index | – | 219 | −2 ± 17% | |
ΔLV ejection fraction | – | 238 | 3 ± 12% |